0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Senti Biosciences Inc - Trending symbols

Latest News of Senti Biosciences Inc

DateTitleRead
2025-05-06
22:35
Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive SENTI-202 Clinical DevelopmentRead
2025-05-01
15:15
Senti Bio Releases Virtual Investor “What This Means” SegmentRead
2025-04-30
15:00
Senti Bio to Present at the Citizens JMP Life Sciences ConferenceRead



Trends

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Net Debt 1,74011,26013,0006,88119,8814,34924,230-38,969-14,739
Depreciation and Amortization 1,474-131,46161,467-31,464-5,856-4,392
Income Tax Expense -11,97410,862-1,112-99-1,211-1,166-2,3772,40528
Inventory 3,919-6303,2892133,502-3513,151-42,728-39,577
EBIT -18,116-2,844-20,9601,126-19,834-1,012-20,84622,5591,713
EBITDA -17,085-2,931-20,0161,052-18,964-671-19,63523,1633,528
Total Other Income Expense Net 4451,3611,806-6941,112-174938-19,951-19,013
Gross Profit 250-191591,2271,286-349937-26,373-25,436
Income before Tax -16,640-1,570-18,210-512-18,72225-18,69740,38921,692
Net Income -16,1959,959-6,236-11,374-17,610-1,087-18,69740,38921,692

Comments

How you think about this?

Leave a comment

Stay informed about Senti Biosciences Inc.

Receive notifications about Senti Biosciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.